News
Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...
2d
Zacks.com on MSNIs Pfizer (PFE) Stock Undervalued Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...
Pharmaceutical stocks tumble as Trump announces imminent “major tariff” on imported drugs. Pfizer, Merck, and Johnson & Johnson shares drop over 4%, dragging the broader S&P 500 lower.
From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...
StockStory.org on MSN19h
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals StocksDetailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Investing in oil company ConocoPhillips (NYSE: COP) was one of the failures during this time, having suffered $1.53 billion loss by mid-2009 as oil prices dropped. Overall, Buffett was not only ...
With a diverse portfolio of eight FDA-approved medications targeting neurological conditions, Supernus Pharmaceuticals ...
Shares of Pfizer Inc. PFE slipped 4.00% to $21.59 Thursday, on what proved to be an all-around dismal trading session for the ...
In recent developments, a class action lawsuit was filed against Cerevel Therapeutics, Bain Capital Investors, and Pfizer ...
Shares of Pfizer Inc. PFE shed 3.49% to $21.84 Tuesday, on what proved to be an all-around poor trading session for the stock ...
15h
Zacks Investment Research on MSNPfizer Stock Falls to New 52-Week Low: Should You Buy the Dip?Pfizer’s PFE stock hit a new 52-week low of $20.92 on Wednesday but recovered thereafter and closed at $22.49 Though the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results